CMA1 and Alzheimer disease: Immunohistochemical staining showed that AD increased the expression levels of CD163 and chymase, but decreased the expression of inducible nitric oxide synthase (iNOS), in an HDAC6-dependent manner (Supplementary Figure S1A).